RED-HF (Completed)
Reduction of Events with Darbepoetin alfa in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Subjects With HF and Anemia.
- Medicine
- darbepoëtine
- Population
- Heart failure
- Phase
- III
- Starting year
- 2006
- More information
- ClinicalTrials.gov